Cardiovascular effects produced by nitric oxide-related drugs in the caudal ventrolateral medulla

NeuroReport

Volumn 10, Issue 4, 1999, Pages 731-735

  Lage, Ricardo C ^a   Campagnole Santos, Maria J ^a   Fontes, Marco A P ^a   Santos, Robson A S ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Blood pressure; Caudal ventrolateral medulla; L Arginine; Nitric oxide; Vasopressin

Indexed keywords

N(G) METHYLARGININE; NITRIC OXIDE; PRAZOSIN; VASOPRESSIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR EFFECT; DRUG EFFECT; HEART RATE VARIABILITY; HYPERTENSION; MALE; MEDULLA OBLONGATA; NONHUMAN; PRIORITY JOURNAL; RAT; VASOPRESSIN RELEASE;

EID: 0033577184     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199903170-00013     Document Type: Article

References (32)

1. 1. Reis DJ, Golanov EV, Ruggiero DA et al. J Hypertens 12 (Suppl. 10), S159-S180 (1994).
2. 2. Feldberg W and Guertzenstein PG. J Physiol 258, 337-335 (1976).
3. 3. Dampney RAL. Physiol Rev 74, 323-364 (1994).
4. 4. Dampney RAL. Prog Neurobiol 42, 197-277 (1994).
5. 5. Chalmers I and Pilowsky P. J Hypertens 9, 675-694 (1991).
6. 6. Bredt DS, Hwang PM and Snyder SH. Nature (Lond) 347, 768-770 (1990).
7. 7. Knowles RG, Palacios M, Palmer RMJ et al. Proc Natl Acad Sci USA 56, 5159-5162 (1989).
8. 8 DiPaola ED, Vidal MN, Nistico G. J Cardiovasc Pharmacol 17, 5269-5272 (1991).
9. 9. Shapoval LN, Sagach VF, Pobegailo LS et al. Neurosci Lett 132, 47-50 (1991).
10. 10. Sakuma I, Togashi H, Yoshioka M et al. Circ Res 70, 607-611 (1992).
11. 11. Togashi H, Sakuma I, Yoshioka M et al. J Pharmacol Exp Ther 262, 343-347 (1992).
12. 12. Tagawa T, Imaizumi T, Harada S et al. Circ Res 75, 70-76 (1994).
13. 13. Zanzinger J, Czachurski J, Seller H et al. Am J Physiol 268, R958-R962 (1995).
14. 14. Hirooka Y, Polson JW, Dampney RAL et al. J Hypertens 14, 1317-1324 (1996).
15. 15 Kagiyama S, Tsuchihashi T, Abe I and Fujishima M. Brain Res 757, 155-158 (1997).
16. 16. Tseng CJ, Liu HY, Lin HC et al. Hypertension 27, 36-42 (1996).
17. 17. Arévalo R, Sanchez F, Alonso JR et al. Brain Res Bull 28, 599-603 (1992).
18. 18. Ohta A, Takagi H, Matsui T et al. Neurosci Lett 158, 33-35 (1993).
19. 19. Dun NJ, Dun SL and Förstermann U. Neuroscience 59, 429-445 (1994).
20. 20. Krukoff TL, Gehlen F, Ganten D et al. Hypertension 26, 171-176 (1995).
21. 21. Griffith OW and Stuehr DJ. Annu Rev Physiol 57, 707-736 (1995).
22. 22. Silva LCS, Fontes MAP, Campagnole-Santos MJ et al. Brain Res 613, 321-325 (1993).
23. 23. Blessing WW, Jaeger CB, Ruggiero DA et al. Brain Res Bull 9, 279-286 (1982).
24. 24. Sawchenco PE and Swanson LW. Brain Res Rev 4, 275-325 (1982).
25. 25. Swanson LW and Sawchenco PE. Annu Rev Neurosci 6, 269-324 (1983).
26. 26. Ciriello J and Calverson MJ. Brain Res 292, 221-228 (1984).
27. 27. Day TA and Renaud LP. Brain Res 303, 233-240 (1984).
28. 28 Blessing WW, Sved AF and Reis DJ. Science 217, 661-663 (1982).
29. 29 Blessing WW, Sved AF and Reis DJ. Clin Exp Hypertens A6, 149-156 (1984).
30. 30. Imazumi T, Grannata AR, Benarroch EE et al. J Hypertens 3, 491-501 (1985).
31. 31. West MJ, Elliot J, Chalmers J et al. Clin Exp Hypertens A6, 157-170 (1984).
32. 32. Sawchenko PE and Swanson LW. Science 214, 683-685 (1981).